Condition: Type2 Diabetes · Type 2 Diabetes Mellitus in Obese · Dysglycemia · Sponsor: Washington University School of Medicine
Investigators propose to study youth across the spectrum of body mass index (BMI) and dysglycemia. This approach will allow investigators to disentangle the relationship of key features of type 2 diabetes (T2D) risk (e.g. obesity) with intermediary physiologic changes (e.g. insulin resistance, inflammation, β-cell dysfunction and dysglycemia) that pose a risk for the brain. Investigators will determine which of these factors are most associated with differences in brain structure and function among groups, over time, and how these effects differ from normal neurodevelopment.
This description comes directly from the study's public registry record.
Mary Borgschulte, RN, BSN, CDE · 314-952-8195 · Mary.b@wustl.edu
Kaeli Spight · 314-362-4721 · kspight@wustl.edu
Always discuss trial participation with your own doctor first.
| Washington University School of Medicine | St Louis, Missouri, United States | Recruiting |
| UPMC Children's Hospital of Pittsburgh | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05277558